Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07321925 · ClinicalTrials.gov registry record
Thermoacoustic Method for Estimating Liver Fat Fraction
A clinical trial of Fatty Liver Disease, Nonalcoholic and MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis), sponsored by Endra Lifesciences.
- Recruiting
- Registry status
- 49
- Enrollment target
- 1
- Study location
NCT07321925 is a study of Fatty Liver Disease, Nonalcoholic and MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis) that is actively recruiting participants, run by Endra Lifesciences. The registered enrollment target is 49 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07321925, a study of Fatty Liver Disease, Nonalcoholic and MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis), is actively recruiting participants, sponsored by Endra Lifesciences.
- RECRUITING
- Registry status
- 49 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to use our Thermoacoustic Enhanced Ultrasound device to measure the fat levels in your liver and compare it to the the gold standard MRI PDFF measurements. Participants will have a scan with our device, then they will go have an abdominal MRI completed. The goal is to create a more accessible device to measure liver fat as it is an indicator for overall health and metabolic diseases.
Conditions Studied
Interventions
- DEVICE Thermoacoustic Enhanced Ultrasound
Study Locations (1)
Michigan
- ENDRA Life Sciences - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2025-08-15 |
| Est. Completion | 2025-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07321925
The ClinicalTrials.gov registry entry for NCT07321925 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 49 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Endra Lifesciences, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Fatty Liver Disease, Nonalcoholic appearing as the primary indexed condition, and to 1 intervention - of which Thermoacoustic Enhanced Ultrasound is the first listed.
NCT07321925 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT07321925 about?
NCT07321925 is a clinical study titled "Thermoacoustic Method for Estimating Liver Fat Fraction". The goal of this study is to use our Thermoacoustic Enhanced Ultrasound device to measure the fat levels in your liver and compare it to the the gold standard MRI PDFF measurements. Participants will have a scan with our device, then they will go have an abdominal MRI completed. The goal is to creat...
What is the current status of trial NCT07321925?
This trial is currently recruiting. The enrollment target is 49 participants. The study started on 2025-08-15. Estimated completion is 2025-12-31.
What conditions does trial NCT07321925 study?
This clinical trial studies the following conditions: Fatty Liver Disease, Nonalcoholic, MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis).
What interventions are being tested in trial NCT07321925?
The interventions under investigation include: Thermoacoustic Enhanced Ultrasound (DEVICE).
Who is sponsoring clinical trial NCT07321925?
This trial is sponsored by Endra Lifesciences, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07321925 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Fatty Liver Disease, Nonalcoholic
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Fatty Liver Disease, Nonalcoholic
All registered trials for this condition
MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis)
All registered trials for this condition
Michigan
All trials with a study site in Michigan
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.